Efficacy and safety of topically applied therapeutic ammonia oxidising bacteria in adults with mild-to-moderate atopic dermatitis and moderate-to-severe pruritus: a randomised, double-blind, placebo-controlled, dose-ranging, phase 2b trial
Open Access
- 16 May 2023
- journal article
- research article
- Published by Elsevier in eClinicalMedicine
- Vol. 60, 102002
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Dysbiosis and Staphylococcus aureus Colonization Drives Inflammation in Atopic DermatitisImmunity, 2015
- Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: A systematic reviewJournal of Allergy and Clinical Immunology, 2014
- Guidelines of care for the management of atopic dermatitisJournal of the American Academy of Dermatology, 2014
- Assessment of Pruritus Intensity: Prospective Study on Validity and Reliability of the Visual Analogue Scale, Numerical Rating Scale and Verbal Rating Scale in 471 Patients with Chronic PruritusActa Dermato-Venereologica, 2012
- Guidelines for treatment of atopic eczema (atopic dermatitis) Part IJournal of the European Academy of Dermatology and Venereology, 2012
- Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitisGenome Research, 2012
- Nitrous oxide production by lithotrophic ammonia-oxidizing bacteria and implications for engineered nitrogen-removal systemsBiochemical Society Transactions, 2011
- The 5-D itch scale: a new measure of pruritusBritish Journal of Dermatology, 2009
- The Patient-Oriented Eczema MeasureArchives of Dermatology, 2004
- The eczema area and severity index (EASI): assessment of reliability in atopic dermatitisExperimental Dermatology, 2001